BioLife Solutions Inc expected to post a loss of 14 cents a share - Earnings Preview

BioLife Solutions

07/08/2024 03:06

* BioLife Solutions Inc  BLFS.OQ   BLFS.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 8
for the period ending June 30 2024
    * The Bothell Washington-based  company is expected to
report a
39.4% decrease in revenue to $23.946 million from $39.51 million
a year ago, according to the mean estimate from 9 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for BioLife Solutions Inc is
for a
loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BioLife
Solutions
Inc is $26.00​, above​ its last closing price of $22.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.28       -0.28      -0.23     Beat    17.9
 Dec. 31 2024              -0.34      -0.30     Beat    12.2
 Jan. 1 0001   -0.38       -0.37      -0.30     Beat    20​
 Jun. 30 2023  -0.21       -0.20      -0.23     Missed  -15
 ​​Mar.        -0.22       -0.21      -0.32     Missed  -51.3
 31 2023                                                
 Dec. 31 2022  -0.20       -0.17      -1.15     Missed  -590​
 Jan. 1 0001   -0.18       -0.17      -0.23     Missed  -35.3
 Jan. 1 0001   -0.23       -0.21      -0.06     Beat    72
 This summary was machine generated August 7 at 02:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)